1. Home
  2. Labeler Index
  3. Golden State Medical Supply, Inc.
  4. 51407-929
  5. NDC Package Code: 51407-929-11 Imuldosa

NDC Package 51407-929-11 Imuldosa

Ustekinumab-srlf Injection Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51407-929-11
Package Description:
1 BLISTER PACK in 1 CARTON / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGE
Product Code:
51407-929
Proprietary Name:
Imuldosa
Non-Proprietary Name:
Ustekinumab-srlf
Substance Name:
Ustekinumab
Usage Information:
Ustekinumab is used to treat plaque psoriasis, a certain type of arthritis (psoriatic arthritis), or certain bowel conditions (Crohn's disease, ulcerative colitis). It works by blocking certain natural proteins in your body (interleukin-12 and interleukin-23) that cause inflammation (swelling) in these conditions. Ustekinumab does not cure these diseases, but helps to lessen symptoms of the disease. It can help to decrease the amount of plaques in plaque psoriasis, decrease the number of swollen/painful joints in psoriatic arthritis, and decrease symptoms such as abdominal pain/cramping and diarrhea in Crohn's disease and ulcerative colitis.
11-Digit NDC Billing Format:
51407092911
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Golden State Medical Supply, Inc.
Dosage Form:
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s):
Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s):
USTEKINUMAB 45 mg/.5mL
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
BLA761364
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
10-10-2024
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 51407-929-11?

The NDC Packaged Code 51407-929-11 is assigned to a package of 1 blister pack in 1 carton / 1 syringe in 1 blister pack / .5 ml in 1 syringe of Imuldosa, a human prescription drug labeled by Golden State Medical Supply, Inc.. The product's dosage form is injection and is administered via subcutaneous form.

Is NDC 51407-929 included in the NDC Directory?

Yes, Imuldosa with product code 51407-929 is active and included in the NDC Directory. The product was first marketed by Golden State Medical Supply, Inc. on October 10, 2024 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 51407-929-11?

The 11-digit format is 51407092911. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-251407-929-115-4-251407-0929-11